X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (1) 1
analysis (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
biomarkers - metabolism (1) 1
breast (1) 1
c-reactive protein (1) 1
c-reactive protein - metabolism (1) 1
cancer (1) 1
cancer patients (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
carcinoma, non-small-cell lung - physiopathology (1) 1
carcinoma, non-small-cell lung - psychology (1) 1
care and treatment (1) 1
cell differentiation (1) 1
chemotherapy (1) 1
chemotherapy drugs (1) 1
cisplatin (1) 1
confusion - chemically induced (1) 1
confusion - metabolism (1) 1
depression - chemically induced (1) 1
depression - metabolism (1) 1
fatigue - chemically induced (1) 1
fatigue - metabolism (1) 1
female (1) 1
hemoglobin (1) 1
hemoglobins - drug effects (1) 1
humans (1) 1
inflammation (1) 1
interleukin-6 - metabolism (1) 1
interleukins (1) 1
leukocytes - drug effects (1) 1
lung cancer (1) 1
lung neoplasms - drug therapy (1) 1
lung neoplasms - physiopathology (1) 1
lung neoplasms - psychology (1) 1
macrophages (1) 1
macrophages - drug effects (1) 1
macrophages - metabolism (1) 1
male (1) 1
mechanisms (1) 1
middle aged (1) 1
monocyte-differentiated macrophages (1) 1
monocytes - drug effects (1) 1
nonsmall cell lung (1) 1
pharmacology & pharmacy (1) 1
phosphatases (1) 1
sleep (1) 1
sleep disorders (1) 1
sleep wake disorders - chemically induced (1) 1
sleep wake disorders - metabolism (1) 1
symptom assessment (1) 1
symptom distress (1) 1
tartrate-resistant acid phosphatase - blood (1) 1
tartrate-resistant acid phosphatase - metabolism (1) 1
tetradecanoylphorbol acetate - therapeutic use (1) 1
thp-1 cells (1) 1
tracp5a (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmacology, ISSN 0014-2999, 03/2019, Volume 846, pp. 38 - 48
Tartrate-resistant acid phosphatase 5a (TRACP5a) is mainly secreted by activated macrophages in chronic inflammation. Serum TRACP5a is associated with symptom... 
TRACP5a | Chemotherapy drugs | Monocyte-differentiated macrophages | Lung cancer | Symptom distress | NONSMALL CELL LUNG | CISPLATIN | INFLAMMATION | MACROPHAGES | PHARMACOLOGY & PHARMACY | MECHANISMS | BREAST | Confusion - chemically induced | Lung Neoplasms - drug therapy | Sleep Wake Disorders - chemically induced | Tartrate-Resistant Acid Phosphatase - blood | Fatigue - metabolism | Humans | Middle Aged | Symptom Assessment | Carcinoma, Non-Small-Cell Lung - psychology | Male | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Lung Neoplasms - physiopathology | Carcinoma, Non-Small-Cell Lung - physiopathology | Sleep Wake Disorders - metabolism | Depression - metabolism | C-Reactive Protein - metabolism | Antineoplastic Agents - adverse effects | Depression - chemically induced | Female | Cell Differentiation | Hemoglobins - drug effects | Interleukin-6 - metabolism | Biomarkers - metabolism | THP-1 Cells | Monocytes - drug effects | Macrophages - metabolism | Confusion - metabolism | Tartrate-Resistant Acid Phosphatase - metabolism | Leukocytes - drug effects | Macrophages - drug effects | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung Neoplasms - psychology | Tetradecanoylphorbol Acetate - therapeutic use | Care and treatment | C-reactive protein | Phosphatases | Macrophages | Sleep disorders | Cancer patients | Chemotherapy | Sleep | Interleukins | Analysis | Hemoglobin | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.